69 related articles for article (PubMed ID: 7956807)
1. [Beta-receptor blockers in dilated cardiomyopathy].
Osterziel KJ
Dtsch Med Wochenschr; 1994 Nov; 119(46):1604-5. PubMed ID: 7956807
[No Abstract] [Full Text] [Related]
2. Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.
Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Matsunaka T; Suzuki J; Shigematsu Y
Heart Vessels; 2002 Dec; 17(2):53-6. PubMed ID: 12541094
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of norepinephrine transporter and adrenergic receptor alpha1D are associated with the response to beta-blockers in dilated cardiomyopathy.
Nonen S; Okamoto H; Fujio Y; Takemoto Y; Yoshiyama M; Hamaguchi T; Matsui Y; Yoshikawa J; Kitabatake A; Azuma J
Pharmacogenomics J; 2008 Feb; 8(1):78-84. PubMed ID: 17404580
[TBL] [Abstract][Full Text] [Related]
4. [Beta-blockade therapy in heart failure. Rational bases of the interpretation of clinical data and clinical evidence in search of rational interpretation].
Branzi A; Rapezzi C
G Ital Cardiol; 1988 Oct; 18(10):843-6. PubMed ID: 2907744
[No Abstract] [Full Text] [Related]
5. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
[TBL] [Abstract][Full Text] [Related]
6. [Case of dilated cardiomyopathy with marked improvement of the cardiac function with beta block treatment and exacerbation with the interruption of the treatment].
Shimizu K; Morimoto S; Yamada K; Hiramitsu S; Uemura A; Kubo N; Kimura K; Kato Y; Kato S; Hishida H
Nihon Naika Gakkai Zasshi; 1997 May; 86(5):840-2. PubMed ID: 9280773
[No Abstract] [Full Text] [Related]
7. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
[TBL] [Abstract][Full Text] [Related]
8. [Beta-adrenoblockers in treatment of dilated cardiomyopathy].
Novikov IuI; Konstantinova EV; Stulova MA
Klin Med (Mosk); 2006; 84(1):11-6. PubMed ID: 16512388
[No Abstract] [Full Text] [Related]
9. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.
De Maria R; Di Lenarda A; Gavazzi A; Porcu M; Sinagra G; Parolini M;
Ital Heart J; 2001 Feb; 2(2):130-8. PubMed ID: 11256541
[TBL] [Abstract][Full Text] [Related]
10. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
[TBL] [Abstract][Full Text] [Related]
11. Beta-blockers in asymptomatic dilated cardiomyopathy: to b-block or not to b-block?
Filippatos G; Kremastinos DT
Eur Heart J; 2007 May; 28(9):1170-1. PubMed ID: 17412729
[No Abstract] [Full Text] [Related]
12. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of heart rate in dilated cardiomyopathy treated with metoprolol.
Perkan A; Di Lenarda A; Sinagra G; Gregori D; Cherubini A; Zecchin M; Gortan R; Klugmann S; Camerini F
G Ital Cardiol; 1997 Nov; 27(11):1106-12. PubMed ID: 9419820
[TBL] [Abstract][Full Text] [Related]
14. Short-term effects of atenolol in patients with dilated cardiomyopathy.
Krittayaphong R; Mahanonda N; Kangkagate C; Phankingthongkum R; Chaithiraphan S
J Med Assoc Thai; 1998 Mar; 81(3):201-7. PubMed ID: 9623012
[TBL] [Abstract][Full Text] [Related]
15. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
[TBL] [Abstract][Full Text] [Related]
16. [Dilated cardiomyopathy].
Gurevich MA; Iankovskaia MO
Sov Med; 1985; (10):30-3. PubMed ID: 2867605
[No Abstract] [Full Text] [Related]
17. Dilated cardiomyopathy : clinical profile and treatment.
Khalil A; Chawla K; Chakravarti A
Indian Pediatr; 2000 Nov; 37(11):1242-6. PubMed ID: 11086307
[No Abstract] [Full Text] [Related]
18. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.
Ahmet I; Krawczyk M; Heller P; Moon C; Lakatta EG; Talan MI
Circulation; 2004 Aug; 110(9):1083-90. PubMed ID: 15313944
[TBL] [Abstract][Full Text] [Related]
20. Increased gene expression of collagen Types I and III is inhibited by beta-receptor blockade in patients with dilated cardiomyopathy.
Shigeyama J; Yasumura Y; Sakamoto A; Ishida Y; Fukutomi T; Itoh M; Miyatake K; Kitakaze M
Eur Heart J; 2005 Dec; 26(24):2698-705. PubMed ID: 16204268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
